JP Patent

JP2005518408A — 異常脂肪血症を治療するための、ｇｌｐ−１化合物と他の薬物との組み合わせ使用

Assigned to Novo Nordisk AS · Expires 2005-06-23 · 21y expired

What this patent protects

GLP-1化合物および他の抗異常脂肪血症薬を投与することを含んでなる、異常脂肪血症の治療のための方法および使用

USPTO Abstract

GLP-1化合物および他の抗異常脂肪血症薬を投与することを含んでなる、異常脂肪血症の治療のための方法および使用

Drugs covered by this patent

Patent Metadata

Patent number
JP2005518408A
Jurisdiction
JP
Classification
—
Expires
2005-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.